Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) EPS (Basic): 2023-2025

Historic EPS (Basic) for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to -$0.08.

  • Compass Therapeutics' EPS (Basic) changed negligibly% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 25.00%. This contributed to the annual value of -$0.36 for FY2024, which is 9.09% down from last year.
  • According to the latest figures from Q3 2025, Compass Therapeutics' EPS (Basic) is -$0.08, which was up 42.86% from -$0.14 recorded in Q2 2025.
  • Over the past 5 years, Compass Therapeutics' EPS (Basic) peaked at -$0.06 during Q1 2023, and registered a low of -$0.14 during Q2 2025.
  • Over the past 3 years, Compass Therapeutics' median EPS (Basic) value was -$0.09 (recorded in 2023), while the average stood at -$0.09.
  • Data for Compass Therapeutics' EPS (Basic) shows a maximum YoY slumped of 50.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Compass Therapeutics' EPS (Basic) stood at -$0.10 in 2023, then decreased by 10.00% to -$0.11 in 2024, then remained steady at -$0.08 in 2025.
  • Its EPS (Basic) stands at -$0.08 for Q3 2025, versus -$0.14 for Q2 2025 and -$0.12 for Q1 2025.